Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja(Sarah Cannon), Deepu Madduri(Mount Sinai Medical Center), Saad Z. Usmani(Levine Cancer Institute), Andrzej Jakubowiak(University of Chicago Medical Center), Mounzer Agha(UPMC Hillman Cancer Center), Adam D. Cohen(University of Pennsylvania), A. Keith Stewart(University Health Network), Parameswaran Hari(Medical College of Wisconsin), Myo Htut(City of Hope), Alexander M. Lesokhin(Memorial Sloan Kettering Cancer Center), Abhinav Deol(Wayne State University), Nikhil C. Munshi(Harvard University), Elizabeth O’Donnell(Harvard University), David Avigan(Beth Israel Deaconess Medical Center), Indrajeet Singh(Janssen (United States)), Enrique Zudaire(Janssen (United States)), Tzu‐Min Yeh(Janssen (United States)), Alicia J. Allred(Janssen (United States)), Yunsi Olyslager(Janssen (Belgium)), Arnob Banerjee(Janssen (United States)), Carolyn C. Jackson(Janssen (United States)), Jenna D Goldberg(Janssen (United States)), Jordan M. Schecter(Janssen (United States)), William Deraedt(Janssen (Belgium)), Sen Hong Zhuang(Janssen (United States)), Jeffrey R. Infante(Janssen (United States)), Dong Geng, Xiaoling Wu, Marlene J. Carrasco-Alfonso, Muhammad Akram, Farah Hossain, Syed Rizvi, Frank Fan, Yi Lin(Mayo Clinic in Arizona), Thomas G. Martin(University of California, San Francisco), Sundar Jagannath(Mount Sinai Medical Center)

The Lancet

June 24, 2021

Cited by 1,635

Abstract

Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al.|New England Journal of Medicine|2017|5.9k

Daniel W. Lee, Bianca Santomasso, Frederick L. Locke et al.|Biology of Blood and Marrow Transplantation|2018|3.4k